COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have moderate to severe COPD (a serious lung condition) and your doctor has recommended starting a specific triple inhaler treatment called BGF, following local prescribing guidelines
- You are already taking part in a related single-arm study (a type of study where all participants receive the same treatment)
- You have agreed to allow your data from that study to be used for additional research purposes
Who may not be able to join:
- You have not given permission for your data to be used for secondary research purposes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael F Pollack, MS, AstraZeneca
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
COPD Assessment Test (CAT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.